- ASCO® 2024
- Yale Cancer Answers
- ASH CME Series
- Smilow Shares with Primary Care
- Grand Rounds
- Head and Neck
- Gynecologic
- Benign Hematology
- Breast
- GI
- Lung
- GU
- Hematologic Oncology
- Brain
- Cancer Screening
- DEI (Diversity, Equity and Inclusion)
- 2021 ASH Highlights
- General Events
- Events
Playback speed
10 seconds
HER2- Stage II/III BC I-SPY 2 Trial Results: Is There Any Activity With PARPi + IO Concurrent With Weekly Paclitaxel?
By
Yale Cancer Center
FEATURING
Lajos Pusztai
By
Yale Cancer Center
FEATURING
Lajos Pusztai
417 views
September 28, 2020
Comments 1
Login to view comments.
Click here to Login
Breast